Outcomes, showing proportions of patients experiencing the various outcomes.
| Outcome | Bio yogurt (%, 95% CI) | Commercial yogurt % (95% CI) | No yogurt % (95% CI) | P-value |
|---|---|---|---|---|
| Trial participants suffering thrush during this study | 10/131 (8, 4 to 12) | 6/118 (5, 2 to 10) | 10/120 (8, 4 to 13) | 0.590 |
| Previous history of thrush associated with antibiotics and experiencing thrush during this study (n = 58) | 6/19 (32, 14 to 52) | 2/20 (10, 3 to 30) | 8/17 (47, 31 to 74) | 0.040 |
| Participants experiencing persistence of symptoms during this study | 17/131 (13, 8 to 19) | 14/118 (12, 7 to 18) | 22/120 (18, 11 to 23) | 0.310 |
| Older patients (aged ≥60 years) experiencing persistence of symptoms during this study (n = 83) | 4/35 (11, 5 to 26) | 1/20 (5, 1 to 24) | 12/28 (43, 27 to 61) | 0.001 |
| Participants suffering abdominal pain on at least 1 day during this study | 66/131 (46, 38 to 54) | 46/118 (39, 35 to 52) | 60/120 (50, 48 to 64) | 0.100 |
| Participants suffering wind (flatulence) on at least 1 day during this study | 86/131 (65, 57 to 73) | 71/118 (60, 51 to 69) | 77/120 (64, 55 to 72) | 0.700 |
| Mean total stool count over the 12 days for individuals participating in this study | 16.1 (14.5 to 17.7) | 16.1 (4.9 to 17.3) | 16.0 (15.2 to 16.9) | 0.996 |
P-values are from χ2 tests except stool counts where a simple ANOVA was used. n = 369 unless stated.